Automated SCORAD and EASI scoring for atopic dermatitis clinical trials. AI-powered automated SCORAD and EASI severity assessment across body areas, validated in JID Innovations (2022). CE-marked medical device.
Peer-reviewed publications behind automated SCORAD and EASI scoring for atopic dermatitis, including the primary automated-SCORAD study and the foundational SCORAD and EASI references.
End-to-end clinical trial workflow for atopic dermatitis severity endpoints, covering protocol design, patient enrolment, image capture, AI scoring, severity tracking, data export, and EDC integration.
How atopic dermatitis images are captured for automated SCORAD and EASI scoring: the standard body-perspective and close-up set, DIQA quality control, patient preparation, and site standardisation.
Transparent documentation of what the automated SCORAD and EASI scoring can and cannot do, including the inherent constraints of photograph-based assessment and how each limitation is managed.
Deep technical detail on the automated SCORAD and EASI scoring pipelines, covering BSA segmentation, intensity sign scoring, SCORAD and EASI formulas, severity scale, and comparison with manual assessment.